Herpes Zoster

• 

  Subject Areas on Research

  • A prospective study of the herpes zoster severity of illness. 
  • A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation. 
  • A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. 
  • A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. 
  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. 
  • Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. 
  • Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. 
  • Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. 
  • An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. 
  • Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. 
  • Antigen-specific T-lymphocyte function after cord blood transplantation. 
  • Are current therapies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature. 
  • Are stressful life events risk factors for herpes zoster? 
  • Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients. 
  • Assessment of pain in herpes zoster: lessons learned from antiviral trials. 
  • Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources. 
  • CSF in herpes zoster meningoencephalitis. 
  • Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults. 
  • Dermatomal sclerodermoid graft-vs-host disease following varicella-zoster virus infection. 
  • Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. 
  • Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. 
  • Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia. 
  • Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. 
  • Dorsal root entry zone lesions in the treatment of pain following brachial plexus avulsion, spinal cord injury and herpes zoster. 
  • Economic burden of herpes zoster among skilled nursing facility residents in the United States. 
  • Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations. 
  • Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. 
  • Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults. 
  • Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. 
  • Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. 
  • Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. 
  • Herpes Zoster Vaccination: Controversies and Common Clinical Questions. 
  • Herpes Zoster. 
  • Herpes Zoster. 
  • Herpes Zoster. 
  • Herpes zoster and postherpetic neuralgia in older adults. 
  • Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. 
  • Herpes zoster in older adults. 
  • Herpes zoster in the elderly: issues related to geriatrics. 
  • Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults. 
  • Infection with varicella-zoster virus after marrow transplantation. 
  • Long-term persistence of zoster vaccine efficacy. 
  • Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. 
  • Management of post-herpetic neuralgia. 
  • Modified varicella-like syndrome. 
  • Natural history and treatment of herpes zoster. 
  • Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. 
  • Postherpetic neuralgia in immunocompetent elderly people. 
  • Postherpetic pain: more than sensory neuralgia? 
  • Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. 
  • Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity. 
  • Race and stress in the incidence of herpes zoster in older adults. 
  • Racial and psychosocial risk factors for herpes zoster in the elderly. 
  • Racial differences in herpes zoster and age at onset of varicella. 
  • Racial differences in the occurrence of herpes zoster. 
  • Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals. 
  • Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT). 
  • Recommendations for the management of herpes zoster. 
  • Roundtable on postherpetic neuralgia--what, why, how long, and what's next? 
  • Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. 
  • Safety and varicella outcomes after varicella zoster immune globulin administration in pregnancy. 
  • Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. 
  • Safety of zoster vaccine in elderly adults following documented herpes zoster. 
  • Shingles. 
  • Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. 
  • The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity. 
  • The accuracy of self-report of herpes zoster. 
  • The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. 
  • The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. 
  • The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. 
  • The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. 
  • The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. 
  • Treatment and prevention of postherpetic neuralgia. 
  • Vaccination against Herpes Zoster and Postherpetic Neuralgia. 
  • Vaccination against herpes zoster in developed countries: state of the evidence. 
  • Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. 
  • Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. 
  • Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. 
  • Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.